Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02441517 |
| Title | A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide |
| Recruitment | Terminated |
| Gender | male |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Astellas Pharma Global Development, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site US10003 | Evanston | Illinois | 60201 | United States | Details | |
| Site US10006 | Worcester | Massachusetts | 01605 | United States | Details | |
| Site US10004 | New York | New York | 10029 | United States | Details | |
| Site US10001 | Charleston | South Carolina | 29425 | United States | Details | |
| Site US10002 | Myrtle Beach | South Carolina | 29572 | United States | Details |